Canada Life’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $207K | Hold |
12,219
| – | – | ﹤0.01% | 1590 |
|
|
2026
Q1 | $182K | Hold |
12,219
| – | – | ﹤0.01% | 1607 |
|
|
2025
Q4 | $195K | Sell |
12,219
-41,295
| -77% | -$585K | ﹤0.01% | 1621 |
|
|
2025
Q3 | $590K | Hold |
53,514
| – | – | ﹤0.01% | 1571 |
|
|
2025
Q2 | $455K | Hold |
53,514
| – | – | ﹤0.01% | 1626 |
|
|
2025
Q1 | $431K | Hold |
53,514
| – | – | ﹤0.01% | 1638 |
|
|
2024
Q4 | $480K | Hold |
53,514
| – | – | ﹤0.01% | 1653 |
|
|
2024
Q3 | $393K | Hold |
53,514
| – | – | ﹤0.01% | 1720 |
|
|
2024
Q2 | $305K | Hold |
53,514
| – | – | ﹤0.01% | 1771 |
|
|
2024
Q1 | $268K | Hold |
53,514
| – | – | ﹤0.01% | 1789 |
|
|
2023
Q4 | $479K | Buy |
53,514
+16,454
| +44% | +$136K | ﹤0.01% | 1709 |
|
|
2023
Q3 | $288K | Buy |
37,060
+30,527
| +467% | +$299K | ﹤0.01% | 1798 |
|
|
2023
Q2 | $64K | Hold |
6,533
| – | – | ﹤0.01% | 1981 |
|
|
2023
Q1 | $72K | Hold |
6,533
| – | – | ﹤0.01% | 2020 |
|
|
2022
Q4 | $28K | Hold |
6,533
| – | – | ﹤0.01% | 2189 |
|
|
2022
Q3 | $49K | Hold |
6,533
| – | – | ﹤0.01% | 2098 |
|
|
2022
Q2 | $66K | Hold |
6,533
| – | – | ﹤0.01% | 1995 |
|
|
2022
Q1 | $86K | Buy |
6,533
+1,192
| +22% | +$18.4K | ﹤0.01% | 2034 |
|
|
2021
Q4 | $122K | Sell |
5,341
-139
| -3% | -$3.29K | ﹤0.01% | 1970 |
|
|
2021
Q3 | $72K | Hold |
5,480
| – | – | ﹤0.01% | 2133 |
|
|
2021
Q2 | $71K | Sell |
5,480
-1,931
| -26% | -$24.6K | ﹤0.01% | 2164 |
|
|
2021
Q1 | $95K | Sell |
7,411
-5,166
| -41% | -$75K | ﹤0.01% | 2110 |
|
|
2020
Q4 | $174K | Sell |
12,577
-105
| -0.8% | -$1.53K | ﹤0.01% | 1998 |
|
|
2020
Q3 | $186K | Buy |
12,682
+739
| +6% | +$10.7K | ﹤0.01% | 1915 |
|
|
2020
Q2 | $193K | Buy |
11,943
+8,372
| +234% | +$134K | ﹤0.01% | 1910 |
|
|
2020
Q1 | $51K | Hold |
3,571
| – | – | ﹤0.01% | 2124 |
|
|
2019
Q4 | $71K | Buy |
+3,571
| New | +$32.9K | ﹤0.01% | 2156 |
|
|
2019
Q3 | – | Sell |
-6,730
| Closed | -$43K | – | 1215 |
|
|
2019
Q2 | $43K | Hold |
6,730
| – | – | ﹤0.01% | 2475 |
|
|
2019
Q1 | $43K | Hold |
6,730
| – | – | ﹤0.01% | 2286 |
|
|
2018
Q4 | $42K | Hold |
6,730
| – | – | ﹤0.01% | 2427 |
|
|
2018
Q3 | $43K | Hold |
6,730
| – | – | ﹤0.01% | 2423 |
|
|
2018
Q2 | $36K | Hold |
6,730
| – | – | ﹤0.01% | 2465 |
|
|
2018
Q1 | $35K | Hold |
6,730
| – | – | ﹤0.01% | 2434 |
|
|
2017
Q4 | $31K | Buy |
+6,730
| New | +$37.4K | ﹤0.01% | 2444 |
|
Other funds holding AUPH
TCM
NMC
Canada Life's AUPH Position: Q2 2026 in Review
Canada Life held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2026 at 12,219 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #1590.
Canada Life first reported a position in AUPH in Q4 2017 and has held it in 34 quarters since. The position peaked at $590K in Q3 2025. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.
- Canada Life held 12,219 shares of Aurinia Pharmaceuticals worth $207K as of Q2 2026.
- Canada Life left its Aurinia Pharmaceuticals share count unchanged in Q2 2026.
- Aurinia Pharmaceuticals made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1590 holding.
- Canada Life first reported a position in Aurinia Pharmaceuticals in Q4 2017 and has held it in 34 quarters since.
- Canada Life's Aurinia Pharmaceuticals position peaked at $590K in Q3 2025.
- 283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.
Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.